Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Arden Partners Plc

4 Apr 2012 16:00

RNS Number : 8482A
Arden Partners plc
04 April 2012
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

ARDEN PARTNERS PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Use a separate form for each party to the offer

ARDEN PARTNERS PLC

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

29 March 2012

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

N/A

NIL

N/A

(2) Derivatives (other than options):

NIL

N/A

NIL

N/A

(3) Options and agreements to purchase/sell:

NIL

N/A

NIL

N/A

TOTAL:

NIL

N/A

NIL

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

NONE

 

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

The following Directors hold interests in and options over ordinary shares of 10 pence each in Arden Partners plc ("Ordinary Shares"):

 

Name of Director

Number of Ordinary Shares Held

Percentage of issued share capital

Options to subscribe for Arden Partners plc Ordinary Shares

Jonathan Keeling

1,506,881

6.09%

-

Trevor Norris

679,600

2.75%

167,399 (1)

Steve Wassell

178,743

0.72%

200,000 (2)

Lord Flight

123,000

0.50%

-

Mark Ansell

50,000

0.20%

-

Peter Moon

50,000

0.20%

-

 

The Arden Partners Employee Benefit Trust Limited holds 974,838 Ordinary Shares representing 3.94% of Arden Partners Plc's issued share capital

 

Notes:

(1) These options were granted under the Arden Partners Limited Share Option Scheme ("the Old Scheme") on 24 April 2006 in his capacity as Executive Director and no performance criteria are attached to the exercise of these options. These options become eligible for exercise on 24 April 2009 at a price of 47.8 pence per share have an expiry date of 24 April 2016.

 

(2) These options were granted on 22 October 2009 under the Arden Partners Share Plan 2007 and no performance criteria are attached to the exercise of these options. These options became eligible for exercise on 31 January 2012 at a price of 10.0 pence per share and have an expiry date of 21 October 2019.

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

04 April 2012

Contact name:

Steve Wassell, Chief Operating Officer

Telephone number:

0207 614 5900

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEEALLLEFDAEFF
Date   Source Headline
11th Mar 202112:30 pmRNSDirector/PDMR Shareholding
11th Mar 202110:55 amRNSHolding(s) in Company
3rd Mar 20218:53 amRNSShare Purchase By Employee Benefit Trust
2nd Mar 20214:11 pmRNSGrant of Options
2nd Mar 202110:21 amRNSShare Purchase by Employee Benefit Trust
18th Feb 20213:38 pmRNSPublication of Annual Report and Notice of AGM
17th Feb 202110:55 amRNSShare Purchase By Employee Benefit Trust
16th Feb 20217:00 amRNSAudited Results For The Year Ended 31 October 2020
11th Feb 20211:17 pmRNSDirector/PDMR Shareholding
12th Jan 20212:27 pmRNSDirector/PDMR Shareholding
11th Dec 202012:54 pmRNSDirector/PDMR Shareholding
11th Nov 20203:13 pmRNSTransaction in Own Shares
27th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
13th Oct 202010:39 amRNSDirector/PDMR Shareholding
8th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
17th Sep 202011:25 amRNSShare Purchase by Employee Benefit Trust
11th Sep 20208:43 amRNSDirector/PDMR Shareholding
7th Sep 202011:04 amRNSShare Purchase by Employee Benefit Trust
4th Sep 202011:57 amRNSShare Purchase by Employee Benefit Trust
11th Aug 20203:43 pmRNSDirector/PDMR Shareholding
11th Aug 20209:15 amRNSShare Purchase by Employee Benefit Trust
29th Jul 20209:05 amRNSShare Purchase by EBT and Holdings in Company
27th Jul 20207:00 amRNSInterim Results - Six Months Ended 30th April 2020
14th Jul 20209:56 amRNSDirector/PDMR Shareholding
9th Jul 20208:38 amRNSHolding(s) in Company
26th Jun 20209:08 amRNSShare Purchase By Employee Benefit Trust
11th Jun 20203:31 pmRNSDirector/PDMR Shareholding
11th Jun 20209:02 amRNSShare Purchase by Employee Benefit Trust
26th May 202011:00 amRNSHolding(s) in Company
26th May 202011:00 amRNSHolding(s) in Company
26th May 202010:58 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSEmployee Incentivisation
21st May 20209:50 amRNSShare Purchase by Employee Benefit Trust
19th May 20207:00 amRNSHolding(s) in Company
12th May 20201:36 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTrading Update
24th Apr 202010:28 amRNSHolding(s) in Company
15th Apr 202012:24 pmRNSDirector/PDMR Shareholding
8th Apr 20208:43 amRNSHolding(s) in Company
30th Mar 202011:55 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 20202:39 pmRNSResult of AGM
20th Mar 20207:00 amRNSStatement Re AGM and Change of Venue
19th Mar 20207:00 amRNSStatement Regarding Share Price Movement
11th Mar 20201:19 pmRNSDirector/PDMR Shareholding
18th Feb 20202:26 pmRNSPublication of Annual Report and Notice of AGM
11th Feb 20202:10 pmRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSPreliminary Results - Year Ended 31 October 2019
13th Jan 20201:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:55 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 201911:00 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.